Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectoral nerve block in mastectomy and breast reconstruction
NCT02913573Phase 2Unknown
- Sponsor
- Huntington Health
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Huntington Health. Primary endpoint: Post-operative pain at 48 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02913573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913573.